Guillain-Barré syndrome. A severe case calling for intensive treatment.
Guillain-Barré syndrome is a relatively common disease with a low mortality rate. Early recognition and institution of treatment lead to a more favorable outcome, especially in more severe cases. Because the patient's condition may deteriorate rapidly, it is crucial to keep the patient in the hospital until his or her condition is confirmed to be stable. Plasmapheresis improves symptoms when instituted within 2 weeks of symptom onset. Treatment with high-dose intravenous immune globulin produces similar results. Speed of recovery varies, but often occurs in a few weeks or months.
Kankam
C G
CG
Kaiser Foundation Research Institute, Department of Medical Editing, Oakland, CA 94612-3429, USA. Edkankam@aol.com
Sallis
R
R
D002648:Child; D006801:Humans; D008297:Male; D011129:Polyradiculoneuropathy / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011379:Prognosis